KAOLIN MIXTURE W PECTIN NF 10 MG
PECTIN : 10 MG KAOLIN : 200 MG · DIN 00238651 · STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC.
Health Canada status: CANCELLED POST MARKET
What is KAOLIN MIXTURE W PECTIN NF?
KAOLIN MIXTURE W PECTIN NF 10 MG contains PECTIN : 10 MG KAOLIN : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 00238651, held by STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC., supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 27-Jul-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00238651 |
|---|---|
| Brand name | KAOLIN MIXTURE W PECTIN NF |
| Generic / active ingredient | PECTIN : 10 MG KAOLIN : 200 MG |
| Manufacturer | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. |
| Strength | 10 MG |
| Dosage form | LIQUID |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07BC30 COMBINATIONS |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 27-Jul-2000 |
| Original market date | 1972-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A07BC30 COMBINATIONS. 0 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DIARET LIQ | 3.078 G / 30 ML | LIQUID | PRODUITS FRANCAIS LABS INC. | CANCELLED POST MARKET | DIN 00540870 |
| DIAREX | 6.156 G / 30 G | LIQUID | PHARMAVITE LABORATORIES (1987) INC. | CANCELLED POST MARKET | DIN 00411949 |
| DONNAGEL-MB SUS | 6 G / 30 ML | SUSPENSION | AYERST LABORATORIES | CANCELLED POST MARKET | DIN 01906542 |
| KAOLIN AND PECTIN SUSP | 200 MG | SUSPENSION | DRUG TRADING COMPANY LTD. | CANCELLED POST MARKET | DIN 00095052 |
| KAOLIN PECTIN SUS | .44 % | SUSPENSION | REGAL PHARMS, DIVISION OF BRADCAN CORPORATION | CANCELLED POST MARKET | DIN 00412570 |
Who else supplies COMBINATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. COMBINATIONS appears in 5 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.